46.19USD+3.29%Mkt Cap: 2.46B $P/E: —1d ago
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a pro…
Indicators:|
Key Statistics
Company
Market Cap2.46B $
Enterprise Value2.38B $
Revenue (TTM)238.10M $
Gross Profit167.35M $
Net Income (TTM)-15.70M $
Revenue/Share4.997 USD
Last Price46.19 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees622
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)63.42
PEG99.04
EV/EBITDA-1112.56
EV/Revenue9.98
P/S10.32
P/B10.03
EPS (TTM)-0.64
EPS (Forward)0.73
52W Range
10.50100% of range46.26
52W High46.26 USD
52W Low10.50 USD
Profitability
Gross Margin74.31%
Oper. Margin-4.61%
EBITDA Margin-0.90%
Profit Margin-6.97%
ROE-12.19%
ROA-7.08%
Growth
Revenue Growth26.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF812.00K $
CapEx (TTM)5.59M $
FCF Margin7.68%
FCF Yield0.74%
Net Debt-80.96M $
Net Debt/EBITDA37.92
Balance Sheet
Debt/Equity0.52
Current Ratio7.10
Quick Ratio4.99
Book Value/Sh4.606 USD
Cash/Share1.911 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJan 27, 2010
Pay DateFeb 12, 2010
Splits
Last Split105:100
Split DateJul 11, 1994
Analyst Consensus
Rating—
Target (Mean)50.78 USD
Upside (mean)+9.9%
Target Range48.00 USD – 55.00 USD
$48.00+9.9% to mean$55.00
# Analysts9
Ownership
Shares Out.53.18M
Float52.13M
Insiders2.19%
Institutions94.73%
Short Interest
Short Ratio3.5d
Short % Float7.98%
Short % Out.6.89%
Shares Short3.66M
Short (prev mo.)3.20M
Technical
SMA 5041.66 (+10.9%)
SMA 20031.25 (+47.8%)
Beta1.12
S&P 52W Chg20.05%
Avg Vol (30d)1.10M
Avg Vol (10d)1.81M
Technical Indicators
RSI (14)63.9
MACD1.1784
MACD Signal1.0442
MACD Hist.+0.1342
BB Upper46.64 USD
BB Middle43.28 USD
BB Lower39.92 USD
BB Width15.51%
ATR (14)2.214 USD
Vol Ratio (20d)0.92x